Monday, 25 September 2023 12:38 GMT

The Global Insulin Market Is Forecast To Grow By $1662.41 Mn During 2022-2027, Accelerating At A CAGR Of 1.77% During The Forecast Period

(MENAFN- GlobeNewsWire - Nasdaq)

New York, Jan. 12, 2023 (GLOBE NEWSWIRE) -- announces the release of the report 'Global Insulin Market 2023-2027' -
Our report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.
The insulin market is segmented as below:
By Type
. Insulin analog
. Human insulin
By Distribution Channel
. Retail pharmacies
. Hospitals
. Online pharmacies
By Geographical Landscape
. North America
. Europe
. Asia
. Rest of World (ROW)
This study identifies the advances in insulin delivery systems as one of the prime reasons driving the insulin market growth during the next few years. Also, increasing focus on home care settings and an increase in awareness of diabetes and growth initiatives will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the insulin market covers the following areas:
. Insulin market sizing
. Insulin market forecast
. Insulin market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp. Also, the insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report:
About reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.